The estimated Net Worth of Lazarus Krikorian is at least 6.12 百万$ dollars as of 7 February 2023. Mr Krikorian owns over 5,711 units of Amerisource Bergen stock worth over 3,371,385$ and over the last 10 years he sold ABC stock worth over 2,745,268$.
Mr has made over 21 trades of the Amerisource Bergen stock since 2015, according to the Form 4 filled with the SEC. Most recently he sold 5,711 units of ABC stock worth 889,888$ on 7 February 2023.
The largest trade he's ever made was exercising 21,802 units of Amerisource Bergen stock on 8 May 2015 worth over 855,947$. On average, Mr trades about 6,212 units every 88 days since 2015. As of 7 February 2023 he still owns at least 18,732 units of Amerisource Bergen stock.
You can see the complete history of Mr Krikorian stock trades at the bottom of the page.
Lazarus Krikorian is the Sr. VP, Chief Accounting Officer & Corp. Controller at Amerisource Bergen.
Mr Krikorian is 56, he's been the Sr. VP、 Chief Accounting Officer & Corp. Controller of Amerisource Bergen since . There are 17 older and 6 younger executives at Amerisource Bergen. The oldest executive at Amerisource Bergen Corp. is Jane Henney, 72, who is the Lead Independent Director.
Lazarus's mailing address filed with the SEC is 1 WEST FIRST AVENUE, , CONSHOHOCKEN, PA, 19428.
Over the last 21 years, insiders at Amerisource Bergen have traded over 4,389,593,610$ worth of Amerisource Bergen stock and bought 18,610 units worth 1,659,872$ . The most active insiders traders include Boots Alliance, Inc.Walgree...、Lon R Greenberg、Steven H Collis. On average, Amerisource Bergen executives and independent directors trade stock every 14 days with the average trade being worth of 13,111,903$. The most recent stock trade was executed by Steven H Collis on 8 August 2023, trading 10,499 units of ABC stock currently worth 813,987$.
amerisourcebergen is driving innovative partnerships with global manufacturers, providers and pharmacies to improve product access and efficiency throughout the healthcare supply chain and enhance patient care. as the leader in global sourcing and distribution, we source and distribute brand, generic, specialty, otc pharmaceuticals and other healthcare products. we increase the effectiveness and efficiency of your supply chain by ensuring products are delivered securely, consistently and cost-effectively, improving product access for pharmacies, providers and patients. our pharmacy solutions result in greater operational efficiency, cost control, growth opportunities and patient safety. our provider solutions drive operational efficiency, financial performance and improve quality of care. our manufacturer solutions maximize success at every stage of the product lifecycle. amerisourcebergen. where knowledge, reach and partnership shape healthcare delivery.
Amerisource Bergen executives and other stock owners filed with the SEC include: